Related Experiment Videos
IgE versus IgG4 production can be differentially regulated by IL-10
P Jeannin1, S Lecoanet, Y Delneste
1Geneva Biomedical Research Institute, Immunology Department, Glaxo Wellcome Research and Development SA, Switzerland.
Journal of Immunology (Baltimore, Md. : 1950)
|April 8, 1998
Summary
Interleukin-10 (IL-10) differentially regulates allergic antibody production. This cytokine reduces immunoglobulin E (IgE) but enhances immunoglobulin G4 (IgG4) synthesis, offering potential therapeutic targets for allergies.
Area of Science:
- Immunology
- Molecular Biology
- Allergy Research
Background:
- Allergen-specific immunoglobulin E (IgE) is central to allergic disease.
- Immunoglobulin G4 (IgG4) production often accompanies IgE responses and may have protective roles.
- Current understanding suggests common regulatory mechanisms for IgE and IgG4 switching.
Purpose of the Study:
- To investigate the differential effects of Interleukin-10 (IL-10) on IgE versus IgG4 production.
- To explore the potential for selective modulation of IgE and IgG4 for therapeutic benefit in allergic disorders.
Main Methods:
- In vitro culture of peripheral blood mononuclear cells (PBMCs).
- Treatment with IL-10 at different time points relative to IL-4 stimulation.
- Analysis of epsilon and gamma4 transcript expression and antibody production.
- Investigation of CD40 ligation effects.
Main Results:
- IL-10 decreased IL-4-induced IgE production when added early in culture, suggesting inhibition of IgE switching.
- IL-10 enhanced IgE production when added to already IgE-switched B cells.
- IL-10 consistently augmented IL-4-induced IgG4 production and transcript expression, regardless of addition timing.
- CD40 ligation reversed IL-10's early inhibitory effect on IgE production.
Conclusions:
- IL-10 exhibits differential regulation of IgE and IgG4 production.
- These findings suggest distinct regulatory pathways for IgE and IgG4 switching.
- IL-10's distinct effects present potential therapeutic strategies for selectively modulating allergic antibody responses.